Floatz logo

Inno-206

Oligodendroglioma of Brain

Oliver JonasEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Oligodendroglioma of Brain cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Oliver Jonas
Early Phase 1C
Cyclophosphamide
Oliver Jonas
Early Phase 1C
ETOPOSIDE
Oliver Jonas
Early Phase 1C
Carboplatin
Oliver Jonas
Early Phase 1C
Ifosfamide
Oliver Jonas
Early Phase 1C

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
Recurrent Adult Acute Lymphoblastic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →